Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 17

Showing 17 citing articles:

Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 10
A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer
Meizi Zhu, Xuejin Lu, Danhong Wang, et al.
Epigenomics (2025), pp. 1-17
Closed Access
Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents
Samima Khatun, Sk. Abdul Amin, Debasmita Choudhury, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 3, pp. 353-368
Closed Access | Times Cited: 3
The Genetically Predicted Causal Associations Between Circulating 3-Hydroxybutyrate Levels and Malignant Neoplasms: A Pan-cancer Mendelian Randomization Study
Fanghang Ye, Yucheng Huang, Liang Zeng, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 11, pp. 137-152
Open Access | Times Cited: 3
Density functional theory (DFT) studies in HDAC-based chemotherapeutics: Current findings, case studies and future perspectives
Samima Khatun, Rinki Prasad Bhagat, Sk. Abdul Amin, et al.
Computers in Biology and Medicine (2024) Vol. 175, pp. 108468-108468
Closed Access | Times Cited: 2
Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design
Samima Khatun, Rinki Prasad Bhagat, Ritam Dutta, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116312-116312
Closed Access | Times Cited: 2
Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
Tong Xiao, Zhigang Chen, Yutong Xie, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 2
HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
T Das, Samima Khatun, Tarun Jha, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 7, pp. 767-784
Closed Access | Times Cited: 2
The Nutriepigenome
Mario G. Mirisola
Genes (2023) Vol. 14, Iss. 11, pp. 1997-1997
Open Access | Times Cited: 2
Histone deacetylase is dysregulated in mesenchymal stromal cells in Philadelphia-negative myeloproliferative neoplasms and functions as potential drug targets
Miaomiao Zhao, Yaogong Wu, Wenjuan He, et al.
Research Square (Research Square) (2024)
Closed Access
Discovery of a dual-target DYRK2 and HDAC8 inhibitor for the treatment of hepatocellular carcinoma
Li Zhang, Lixia Guan, Yuting Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116839-116839
Open Access
HDAC8 as a target in drug discovery: function, structure and design
Qianlong Zhao, Hongyan Liu, Jie Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116972-116972
Closed Access
Histone deacetylase 8 in focus: Decoding structural prerequisites for innovative epigenetic intervention beyond hydroxamates
Samima Khatun, Indrasis Dasgupta, Sudip Sen, et al.
International Journal of Biological Macromolecules (2024) Vol. 284, pp. 138119-138119
Closed Access
Mechanisms of resistance to histone deacetylase inhibitors in acute leukemia
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Mohammad‐Salar Hosseini
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access
Nitrogen-containing heterocycles as important scaffold for selective and potent HDAC8 inhibition: a step towards effective, non-toxic and selective HDAC8 inhibitor discovery
Samima Khatun, Rakibul Islam, Sk. Abdul Amin, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access
Exploring the potential of Andrographis paniculata for developing novel HDAC inhibitors: an in silico approach
Debalina Das, Ritesh Banerjee, Maumita Bandyopadhyay, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 1
Machine learning-based integration develops multi regulated cell death-related signatures for improving outcomes and immune response in acute myeloid leukemia
Lin Li, Rui Zhang, Jinming Li
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top